The impotence of price controls: Failed attempts to constrain pharmaceutical expenditures in Greece-Reference-Cited by-同舟云学术

The impotence of price controls: Failed attempts to constrain pharmaceutical expenditures in Greece

Published:2011-07 Issue:2 Volume:101 Page:162-171
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Lambrelli Dimitra,O’Donnell Owen

Publisher

Elsevier BV

Subject

Health Policy

Reference53 articles.

1. OECD Health Data; 2009.

2. Tragakis E, Polyzos N. Health Care Systems in Transition, Greece; 1996.

3. Generics market in Greece: the pharmaceutical industry's beliefs;Geitona;Health Policy,2006

4. Kousoulakou H, Fragoulakis V. Pharmaceutical market in Greece. Foundation for Economic and Industrial Research (IOBE), Athens; 2004.

5. European Federation of Pharmaceutical Industries and Associations (EFPIA). The pharmaceutical industry in figures. Key data 2007 update, Brussels; 2007.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sociopolitical reputation and the reform of pharmacies in Greece and Portugal;Journal of Public Policy;2023-11-15

2. Exploring the impact of clawback on pharmaceutical expenditure: A case study of public hospitals in Greece;The International Journal of Health Planning and Management;2023-07-21

3. The impact of policy on availability and price of low‐price medicines in public healthcare institutions: A retrospective survey in Nanjing, China;The International Journal of Health Planning and Management;2021-11-30

4. The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China;International Journal of Environmental Research and Public Health;2020-12-15

5. Do cost containment policies save money and influence physicians’ prescribing behavior? Lessons from South Korea’s drug policy for diabetes medication;International Journal for Quality in Health Care;2018-05-17